Company Profiles

driven by the PitchBook Platform

Curemark

Description

Developer of drugs for the treatment of neurological diseases. The company offers biomarker and pancreatic enzyme products for diagnosing and treating children with autism spectrum disorders. It develops drugs for gastrointestinal and pancreatic secretory deficiencies in neurological conditions for children and adults as well as for dysautonomias, including familial dysautonomia and Parkinson's diseases.

2004

Founded

PRIVATE

Status

11-50

Employees

Angel

Latest Deal Type

$20M

Latest Deal Amount

$55.5M

Total Amount Raised

Description

Developer of drugs for the treatment of neurological diseases. The company offers biomarker and pancreatic enzyme products for diagnosing and treating children with autism spectrum disorders. It develops drugs for gastrointestinal and pancreatic secretory deficiencies in neurological conditions for children and adults as well as for dysautonomias, including familial dysautonomia and Parkinson's diseases.

Website:

www.curemark.com

Ownership Status

Privately held (backing)

Financing Status

Angel-Backed

Primary Industry

Pharmaceuticals

Other Industries

Drug Discovery
Biotechnology

Primary Office

411 Theodore Fremd Avenue Rye, NY 10580United States +1 (914) 925-3450
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Curemark's full profile, request a free trial.

Curemark Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Curemark Investors (3)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Aayush PhumbhraAngel (individual)Minority000 0000000 0000
Frist FamilyOtherMinority000 0000000 0000
Individual InvestorAngel (individual)Minority000 0000000 0000
Aayush Phumbhra Angel (individual)
Frist Family Other
Individual Investor Angel (individual)

Curemark Executive Team (6)

NameTitleBoard
Seat
Contact
Info
Joan FallonChief Executive Officer, Founder & Board Member
Jzaneen LalaniChief Operating Officer
Matthew Heil Ph.DChief Scientific Officer
William Gannon Jr.Medical Director
Elisa ZinbergSenior Vice President, Operations
Joan Fallon Chief Executive Officer, Founder & Board Member
Jzaneen Lalani Chief Operating Officer
Matthew Heil Ph.D Chief Scientific Officer
William Gannon Jr. Medical Director
Elisa Zinberg Senior Vice President, Operations

Curemark Board Members (5)

NameRepresentingRoleSinceContact
Info
Eric HermanSelfBoard Member000 0000
Jennifer FristCuremarkBoard Member000 0000
Justin Stebbing Ph.DCuremarkBoard Member000 0000
Kimball DuncanSelfBoard Member000 0000
Klaus KleinfeldSelfBoard Member000 0000
Eric Herman Board Member Self
Jennifer Frist Board Member Curemark
Justin Stebbing Ph.D Board Member Curemark
Kimball Duncan Board Member Self
Klaus Kleinfeld Board Member Self
Request full access to PitchBook